HomeIBT-B • STO
add
Infant Bacterial Therapeutics AB
Previous close
kr 58.40
Day range
kr 55.70 - kr 58.80
Year range
kr 31.20 - kr 84.30
Market cap
758.96M SEK
Avg Volume
7.60K
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
| (SEK) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 20.54M | -45.15% |
Net income | -19.20M | 43.13% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 144.01M | -35.53% |
Total assets | 161.75M | -32.48% |
Total liabilities | 56.42M | -18.60% |
Total equity | 105.33M | — |
Shares outstanding | 13.47M | — |
Price to book | 7.47 | — |
Return on assets | -30.20% | — |
Return on capital | -44.71% | — |
Cash Flow
Net change in cash
| (SEK) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -19.20M | 43.13% |
Cash from operations | -20.09M | -146.62% |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | -21.25M | -656.46% |
Free cash flow | -14.88M | -297.05% |
About
Founded
2011
Website
Employees
8
